US OptionsDetailed Quotes
BSX240830C64000
- 0.00
- 0.000.00%
15min DelayClose Aug 29 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest64.00Strike Price0.00Turnover0.00%IV-20.66%PremiumAug 30, 2024Expiry Date16.67Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma4.86Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Boston Scientific Stock Discussion
Sign in to post a comment
The Federal Reserve appears poised to cut interest rates later this year. While the broader stock market might breathe a sigh of relief, certain sectors could be more significantly impacted than others. Biotechnology could be one of those sectors - at least, that's what Morgan Stanley believes.
In 2024, biotech stocks had a slow start, with the S&P Biotechnology Select Industry Index returning just under 4% in the first six months, compared to...
In 2024, biotech stocks had a slow start, with the S&P Biotechnology Select Industry Index returning just under 4% in the first six months, compared to...
25
1
$Boston Scientific (BSX.US)$ Must have on investment portfolio. Hold long term on this one because I can see it has strong solvency and successful expansion of operations across different geographies outside the United States. Within the APAC , Boston Scientific has strong manufacturing presence and growth and name. (Impossible to miss the manu factory as I drive pass home everyday😂) Its recent acquisitions and profit indicates positive revenue growth in the long term.
3
1
Morning Movers
Gapping up
$Enphase Energy (ENPH.US)$ 's stock went up by 2.3% after the company reported a better-than-expected operating profit for the second quarter, buoyed by renewed demand in the U.S. market.
$Texas Instruments (TXN.US)$ stock increased by 1.7% as the semiconductor company reported stronger-than-expected earnings for the second quarter, with adjusted earnings per share that exceeded estimates.
$AT&T (T.US)$ ...
Gapping up
$Enphase Energy (ENPH.US)$ 's stock went up by 2.3% after the company reported a better-than-expected operating profit for the second quarter, buoyed by renewed demand in the U.S. market.
$Texas Instruments (TXN.US)$ stock increased by 1.7% as the semiconductor company reported stronger-than-expected earnings for the second quarter, with adjusted earnings per share that exceeded estimates.
$AT&T (T.US)$ ...
Expand 30
1
At the start of the week, around 20% of the S&P 500 companies that had reported their second-quarter earnings, with 80% of them topping expectations, according to FactSet data. $S&P 500 Index (.SPX.US)$
Investors have largely priced in the chances of the Federal Reserve cutting interest rates at its September meeting. Combined with rising confidence in a soft landing, the market has continued its rally, with rate-sensitive sectors such as small caps and industrials rising in recent weeks. $Russell 2000 Index (.RUT.US)$
...
Investors have largely priced in the chances of the Federal Reserve cutting interest rates at its September meeting. Combined with rising confidence in a soft landing, the market has continued its rally, with rate-sensitive sectors such as small caps and industrials rising in recent weeks. $Russell 2000 Index (.RUT.US)$
...
1
1
, looking, hoping to get the retail ![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
to keep buying and bail out the crash in a new fashion, trading app RETAIL 
.
The stock price of $Intuitive Surgical (ISRG.US)$ , the maker of Da Vinci surgical robot system surged 9.34% after its earnings report on Friday, and its market value exceeded $160 billion.
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $52...
Second quarter revenue of $2.01 billion increased by 14% compared with $1.76 billion in the second quarter of 2023. The second quarter GAAP net income attributable to Intuitive was $52...
+1
24
1
$Boston Scientific (BSX.US)$
Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
Boston Scientific To Acquire Silk Road Medical For $1.16B In Cash, Offering $44 Per Share; 30% Premium Over Last Closing Price; Deal To Enhance Neurovascular Portfolio And Close By Q4 2024 Pending Regulatory Approvals
1
$Boston Scientific (BSX.US)$
NEWS
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
Positive
MODULAR ATP study met all safety and efficacy endpoints.
Major complication-free rate of 97.5% for EMPOWER LP.
Communication success rate of 98.8% between EMBLEM S-ICD and EMPOWER LP.
ATP success rate of 61.3% with no patient therapy deactivations due to discomfort.
Pacing capture thresholds met in 97.4% of patients.
Positive clinical performance suggests a potential upgrad...
NEWS
MODULAR ATP Study of the mCRM™ System Meets Primary Safety and Efficacy Endpoints
Positive
MODULAR ATP study met all safety and efficacy endpoints.
Major complication-free rate of 97.5% for EMPOWER LP.
Communication success rate of 98.8% between EMBLEM S-ICD and EMPOWER LP.
ATP success rate of 61.3% with no patient therapy deactivations due to discomfort.
Pacing capture thresholds met in 97.4% of patients.
Positive clinical performance suggests a potential upgrad...
Columns Options Market Statistics: Tesla Stock Jumps on Accelerated Production Plans Despite Earnings Miss
News Highlights
$Tesla (TSLA.US)$ shares rose by 1.85%, closing at $144.68. Its options trading volume was 1.75 million. Call contracts account for 44.8% of the total trading volume. The most traded calls are contracts of $160 strike price that expire on Apr. 26th. The total volume reaches 48,736 with an open interest of 28,774. The most traded puts are contracts of a $140 strike price that expires o...
$Tesla (TSLA.US)$ shares rose by 1.85%, closing at $144.68. Its options trading volume was 1.75 million. Call contracts account for 44.8% of the total trading volume. The most traded calls are contracts of $160 strike price that expire on Apr. 26th. The total volume reaches 48,736 with an open interest of 28,774. The most traded puts are contracts of a $140 strike price that expires o...
25
3
Insiders selling Boston Scientific shares, even below current price, is discouraging. Yet, high insider ownership could imply company's interest in all shareholders.
1
Boston Scientific's high P/E ratio is attributed to investors' optimism about its strong future growth and market outperformance. Shareholders' confidence in the company's future earnings supports the current P/E ratio and share price.
1
No comment yet
104026079 : Good info, please post sector wise impacts on Fed Rate Cuts